Jane Street’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-210,900
| Closed | -$8.48M | – | 11468 |
|
|
2026
Q1 | $8.48M | Sell |
210,900
-52,100
| -20% | -$1.12M | ﹤0.01% | 2749 |
|
|
2025
Q4 | $6.61M | Sell |
263,000
-38,500
| -13% | -$903K | ﹤0.01% | 2832 |
|
|
2025
Q3 | $6.82M | Buy |
301,500
+96,000
| +47% | +$2.24M | ﹤0.01% | 2953 |
|
|
2025
Q2 | $3.56M | Buy |
205,500
+108,100
| +111% | +$2M | ﹤0.01% | 3489 |
|
|
2025
Q1 | $2.13M | Sell |
97,400
-99,800
| -51% | -$2.76M | ﹤0.01% | 4253 |
|
|
2024
Q4 | $6.29M | Sell |
197,200
-283,800
| -59% | -$8.53M | ﹤0.01% | 2377 |
|
|
2024
Q3 | $13.9M | Buy |
481,000
+25,000
| +5% | +$926K | ﹤0.01% | 1585 |
|
|
2024
Q2 | $17.5M | Buy |
456,000
+154,700
| +51% | +$7.01M | ﹤0.01% | 1445 |
|
|
2024
Q1 | $17.7M | Sell |
301,300
-727,700
| -71% | -$46.4M | ﹤0.01% | 1297 |
|
|
2023
Q4 | $61.6M | Buy |
1,029,000
+149,500
| +17% | +$7.58M | 0.02% | 586 |
|
|
2023
Q3 | $33.5M | Buy |
879,500
+696,800
| +381% | +$30.6M | 0.01% | 752 |
|
|
2023
Q2 | $16.6M | Sell |
182,700
-76,500
| -30% | -$6.6M | 0.01% | 1395 |
|
|
2023
Q1 | $17.1M | Sell |
259,200
-69,500
| -21% | -$4.01M | 0.01% | 1112 |
|
|
2022
Q4 | $17M | Sell |
328,700
-25,900
| -7% | -$1.37M | 0.01% | 1126 |
|
|
2022
Q3 | $24.2M | Buy |
354,600
+206,100
| +139% | +$12.2M | 0.01% | 918 |
|
|
2022
Q2 | $6.71M | Buy |
148,500
+24,100
| +19% | +$1.1M | ﹤0.01% | 2240 |
|
|
2022
Q1 | $6.32M | Buy |
124,400
+85,500
| +220% | +$3.77M | ﹤0.01% | 2649 |
|
|
2021
Q4 | $1.84M | Sell |
38,900
-228,700
| -85% | -$9M | ﹤0.01% | 4644 |
|
|
2021
Q3 | $8.82M | Buy |
267,600
+176,600
| +194% | +$9.92M | ﹤0.01% | 1962 |
|
|
2021
Q2 | $5.75M | Buy |
91,000
+29,200
| +47% | +$1.51M | ﹤0.01% | 2431 |
|
|
2021
Q1 | $2.65M | Buy |
61,800
+15,200
| +33% | +$719K | ﹤0.01% | 3494 |
|
|
2020
Q4 | $2.67M | Buy |
+46,600
| New | +$1.97M | ﹤0.01% | 2996 |
|
|
2020
Q3 | – | Sell |
-34,200
| Closed | -$1.12M | – | 7106 |
|
|
2020
Q2 | $1.12M | Buy |
+34,200
| New | +$1.1M | ﹤0.01% | 3901 |
|
Other funds holding APLS
Jane Street's APLS Position: Q1 2026 in Review
Jane Street sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 50,114 shares — an estimated $1.08M sold.
Jane Street first reported a position in APLS in Q2 2019 and held it in 26 quarters. The position peaked at $43.8M in Q2 2023. 324 funds tracked by Wall St. Rank hold APLS as of Q1 2026.
- Jane Street reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 50,114 Apellis Pharmaceuticals shares in Q1 2026, an estimated $1.08M.
- Jane Street first reported a position in Apellis Pharmaceuticals in Q2 2019 and held it in 26 quarters.
- Jane Street's Apellis Pharmaceuticals position peaked at $43.8M in Q2 2023.
- 324 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.